All News
|
News Release
A small portion of adults in remission from a deadly blood cancer had persisting mutations detected, which predicted their risk of death from having the cancer return Researchers at the National Institutes of Health show the benefits of screening adult patients in remission from acute myeloid leukemia (AML) for residual disease before receiving a...
Showing 10 out of 288 results
|
News Release
A small portion of adults in remission from a deadly blood cancer had persisting mutations detected, which predicted their risk of death from having the cancer return Researchers at the National Institutes of Health show the benefits of screening adult patients in remission from acute myeloid leukemia (AML) for residual disease before receiving a...
|
News Release
NIH-supported studies show variations in symptoms and diagnostic experiences among different racial and ethnic groups Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID, a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed...
|
News Release
Many adults experience problems like coughing, chest pain, and fatigue six months after their stay About half of adults treated at hospitals for COVID-19 have experienced lingering symptoms, financial difficulties, or physical limitations months after being discharged, according to a National Institutes of Health-supported study published in JAMA...
|
News Release
NIH-supported physician-scientists are studying how primary care providers can identify and treat more people with chronic obstructive pulmonary disease A new tool shows promise in helping primary care physicians identify adults with undiagnosed chronic obstructive pulmonary disease (COPD), according to research published in JAMA. More than 15...
|
Media Advisory
What Leaders from the National Institutes of Health and partner organizations outline NIH’s COVID-19 research response in a policy forum in the journal Science. The authors also reflect on crucial lessons learned that will inform the public health research response to future pandemics. The authors emphasize that by building on decades of basic and...
|
News Release
Large NIH-supported study showed that rural-dwelling Black men are at greatest risk Adults living in rural areas of the United States have a 19% higher risk of developing heart failure compared to their urban counterparts, and Black men living in rural areas have an especially higher risk – 34%, according to a large observational study supported by...
|
Statement
Findings from a randomized, non-blinded, phase 3 clinical trial supported by the National Institutes of Health found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies for sepsis. The findings were published in the New England Journal of Medicine and were...
|
News Release
NIH-funded clinical trial underscores need for better treatments for deadly condition Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The...
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces new director of its Division of Blood Diseases and Resources WHO: Julie Panepinto, M.D., MSPH WHEN: Dr. Panepinto will start her new NHLBI position on January 15, 2023. WHERE: NHLBI of the National Institutes of Health BRIEF BIOGRAPHY: Dr. Julie Panepinto, a pediatric...
|
News Release
NIH-supported study finds no serious complications following rare immune condition A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence. About half of participants experienced...